Pediatrics Doctors in Scituate, MA Accepting Medicare

8 Pediatrics doctors found. Showing 1 - 8

Mr. Julian C Huang, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 10 New Driftway, Ste 201, Scituate, MA 02066 Phone: 781-545-9225    Fax: 781-545-8560

Dr. Sarah M Axel, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 46 Scituate Ave, Scituate, MA 02066 Phone: 617-653-7281

Mrs. Jeanette S Parris, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 10 New Driftway, Ste 201, Scituate, MA 02066 Phone: 781-545-9225    Fax: 781-545-8560

Katie L Mcbrine, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 10 New Driftway, Suite 201, Scituate, MA 02066 Phone: 781-545-9225    Fax: 781-545-8560

Bartley Gray Cilento Sr., MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7 New Driftway, Scituate, MA 02066 Phone: 781-545-3391    Fax: 781-545-7270

Dr. Donna A Zambuto, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 10 New Driftway, Ste 201, Scituate, MA 02066 Phone: 781-545-9225    Fax: 781-545-8560

Mr. David Peter Morin, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10 New Driftway, Suite 201, Scituate, MA 02066 Phone: 781-545-9225    Fax: 781-545-8560

Mr. Alexander Marcus, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 10 New Driftway, Suite 201, Scituate, MA 02066 Phone: 781-545-9225    Fax: 781-545-8560

News Archive

Results from Phase I dose-escalation study of AT-101 announced

Ascenta Therapeutics announced today that encouraging results from a Phase I dose-escalation study of two combination therapy regimens containing AT-101, an oral, pan-Bcl-2 inhibitor, in patients with the most malignant type of brain tumor, were described in an oral presentation at the 2009 Joint Meeting of the Society for NeuroOncology (SNO) and AANS/CNS Section on Tumors in New Orleans, Louisiana (Concurrent Session VI: Radiation Oncology, October 23, 2009; Abstract # 449).

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

ViiV Healthcare today announced the start of a Phase III clinical trial programme to evaluate the safety and efficacy of dolutegravir (Tivicay) and rilpivirine (Edurant) as maintenance therapy for adult patients with HIV.

FDA clears MASEP Infini's gamma ray neurosurgery system

MASEP Infini, an innovator in global medical technology, today announced 510(k) clearance from the U.S. Food and Drug Administration of its new Infini gamma ray neurosurgery system with patented Independent Beam Switch Control with Programmable Arcs, automated collimator exchange and three-dimensional patient positioning, and MASEP Infini's proven Rotary Focusing technology.

Psychopathology persists in ultra-high-risk psychosis patients

Patients at ultra-high-risk for psychosis frequently have nonpsychotic disorders and often continue to experience attenuated psychotic symptoms, even if they do not transition to clinical psychosis, a study shows.

Read more Medical News

› Verified 5 days ago